CCL2 and breast cancer: Similarly, an increase in osteoblast derived cytokines (e.g., IL-6, IL-8, MCP-1, macrophage-inflammatory protein 2 (MIP-2), and vascular endothelial growth factor (VEGF)) has been identified upon the presence of MDA-MB-231 breast cancer cells.